Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.1.30EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.30EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.30ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.1.30ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.1.30EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.1.30EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.1.30ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.30ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
XDA.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XDA.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDA.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XDA.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XDA.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XDA.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XDA.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDA.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.58.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.58.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.58.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.1.58.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.1.58.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.1.58.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.1.58.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.58.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HH.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HH.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HH.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HH.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HH.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HH.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HH.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HH.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.29EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HK.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.29ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HK.29ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HK.29EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HK.29EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HK.29ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.29ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.3.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FY.3.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.3.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FY.3.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FY.3.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FY.3.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FY.3.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FY.3.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.3.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.2.3.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used